James Gordon to Middle Aged
This is a "connection" page, showing publications James Gordon has written about Middle Aged.
Connection Strength
0.262
-
Zemon VM, Gordon J. Quantification and statistical analysis of the transient visual evoked potential to a contrast-reversing pattern: A frequency-domain approach. Eur J Neurosci. 2018 07; 48(2):1765-1788.
Score: 0.050
-
Nunez V, Shapley RM, Gordon J. Nonlinear dynamics of cortical responses to color in the human cVEP. J Vis. 2017 09 01; 17(11):9.
Score: 0.047
-
Abramov I, Gordon J. Color vision panel tests: a metric for interpreting numeric analytic indices. Optom Vis Sci. 2009 Feb; 86(2):146-52.
Score: 0.026
-
Gordon J, Abramov I. Color appearance: Maxwellian vs. Newtonian views. Vision Res. 2008 Aug; 48(18):1879-83.
Score: 0.025
-
Zemon V, Gordon J. Luminance-contrast mechanisms in humans: visual evoked potentials and a nonlinear model. Vision Res. 2006 Nov; 46(24):4163-80.
Score: 0.022
-
Gordon J, Shapley R. Brightness contrast inhibits color induction: evidence for a new kind of color theory. Spat Vis. 2006; 19(2-4):133-46.
Score: 0.021
-
Abramov I, Gordon J. Seeing unique hues. J Opt Soc Am A Opt Image Sci Vis. 2005 Oct; 22(10):2143-53.
Score: 0.021
-
Bergson Z, Ahmed AO, Bell J, Butler PD, Gordon J, Seitz AR, Silverstein SM, Thompson JL, Zemon V. Visual remediation of contrast processing impairments in schizophrenia: A preliminary clinical trial. Schizophr Res. 2024 12; 274:396-405.
Score: 0.019
-
Felip E, Hirsh V, Popat S, Cobo M, F?l?p A, Dayen C, Trigo JM, Gregg R, Waller CF, Soria JC, Goss GD, Gordon J, Wang B, Palmer M, Ehrnrooth E, Gadgeel SM. Symptom and Quality of Life Improvement in LUX-Lung 8, an Open-Label Phase III Study of Second-Line Afatinib Versus Erlotinib in Patients With Advanced Squamous Cell Carcinoma of the Lung After First-Line Platinum-Based Chemotherapy. Clin Lung Cancer. 2018 01; 19(1):74-83.e11.
Score: 0.012
-
Krinsky-McHale SJ, Silverman W, Gordon J, Devenny DA, Oley N, Abramov I. Vision deficits in adults with Down syndrome. J Appl Res Intellect Disabil. 2014 May; 27(3):247-63.
Score: 0.009
-
Zemon V, Tsai JC, Forbes M, Al-Aswad LA, Chen CM, Gordon J, Greenstein VC, Hu G, Strugstad EC, Dhrami-Gavazi E, Jindra LF. Novel electrophysiological instrument for rapid and objective assessment of magnocellular deficits associated with glaucoma. Doc Ophthalmol. 2008 Nov; 117(3):233-43.
Score: 0.006
-
Butler PD, Schechter I, Zemon V, Schwartz SG, Greenstein VC, Gordon J, Schroeder CE, Javitt DC. Dysfunction of early-stage visual processing in schizophrenia. Am J Psychiatry. 2001 Jul; 158(7):1126-33.
Score: 0.004